Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 S395-p
Chk1 T84-p
Regulatory protein:
ALK S354-p
PRKD1 S338-p , S370-p
PRP4 S335-p
TBK1 S354-p
Treatment:
angiotensin-(1-7) S344-p
angiotensin_2 S344-p , S354-p , S407-p , S410-p
anti-CD3 S335-p , S344-p , S359-p , S370-p , S395-p
AZD1152 S329-p , S335-p , S344-p
BI2536 S58-p , S62-p , S329-p , T333-p , S335-p , S344-p , S370-p
BI_4834 S24-p , S370-p
dasatinib S321-p , S370-p
EGF S344-p , S354-p
gefitinib S407-p
imatinib S407-p , S410-p , S411-p
ischemia S321-p , S344-p , S395-p , S407-p
lapatinib S335-p , S338-p , S344-p
metastatic potential S344-p , S395-p
MLN8054 S24-p , S58-p , S62-p , T333-p
nocodazole S24-p , S62-p , S321-p , S335-p , S344-p , S395-p
selumetinib S354-p , S407-p
SII_angiotensin_2 S24-p , T28-p , S354-p , S370-p , S407-p , S410-p
Su11274 S407-p , S410-p , S411-p
U0126 S354-p , S407-p , S410-p , S411-p , S414-p
vemurafenib S354-p , S407-p
ZM447439 S329-p , S335-p , S344-p